Shanghai Kehua Bio-engineering Co Ltd.
002022
Overview
Corporate Details
- ISIN(s):
- CNE000001KC9
- LEI:
- Country:
- China
- Address:
- N/A
- Website:
- N/A
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
Automate Your Workflow. Get a real-time feed of all Shanghai Kehua Bio-engineering Co Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Shanghai Kehua Bio-engineering Co Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shanghai Kehua Bio-engineering Co Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops oral ACLY inhibitors to lower high LDL-C and cardiovascular risk.
United States of America
ESPR
United States of America
ESPR
Develops novel small molecule drugs to treat castration-resistant prostate cancer.
United States of America
EPIX
United States of America
EPIX
Clinical-stage biopharma developing ARTEMIS® T-cell therapies for cancer & autoimmune disease.
United States of America
ESLA
United States of America
ESLA
Develops and commercializes innovative treatments for rare pediatric diseases.
United States of America
ETON
United States of America
ETON
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea
206650
South Korea
206650
Developing targeted, extended-release therapies for GI and musculoskeletal diseases.
United States of America
EPRX
United States of America
EPRX
A SPAC acquiring European biomanufacturers to create a large-scale CDMO for advanced therapies.
France
KINGS
France
KINGS
Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.
France
EAPI
France
EAPI
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
France
ALERS
France
ALERS
Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.
Sweden
EURI B
Sweden
EURI B